Study of Xinglou Chengqi Granule for recent stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a Chinese herbal granule (Xinglou Chengqi) given to people hospitalized with a recent ischemic stroke (within 7 days). It looks at whether the medicine can help improve recovery when added to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 70 years old.
- You had an ischemic stroke within the past 7 days and are in the hospital.
- Your stroke is moderate (NIHSS score between 6 and 19, not severe).
- You have not received or planned clot-busting drugs or clot removal procedures for this stroke.
- You are not allergic to any ingredients in the study granule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.
This study tests whether two herbal medicines (Dengzhan Xixin and Dengzhan Shengmai) can help people recover better after a recent stroke. Researchers will track how these medicines work in your body over time.
This study tests whether a Chinese herbal capsule, Getong Tongluo, can help people recover from a recent ischemic stroke (a stroke caused by a blocked blood vessel in the brain). Researchers want to see if it improves symptoms and understand how it works.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.